title: Genzyme, though unique, could be a bellwether for US biotech.
authors.forename: Elie
authors.initials: E
authors.lastname: Dolgin
mesh_terms: D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D001709:Biotechnology; D001900:Boston; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration; D006801:Humans; D007938:Leukemia / Q000628:therapy; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000074323:Alemtuzumab